Predictors of Maintenance of Long-term Remission in Crohn's Disease Patients Treated With Certolizumab Pegol: Multivariate and Univariate Analyses From the PRECiSE 3 Study

Sandborn William; Schreiber Stefan; Siegel Corey; Melmed Gil; McGovern Dermot; Pierre-Louis Bosny; Kosutic Gordana; Spearman Marshall

首页> 外文期刊>The American Journal of Gastroenterology >Predictors of Maintenance of Long-term Remission in Crohn's Disease Patients Treated With Certolizumab Pegol: Multivariate and Univariate Analyses From the PRECiSE 3 Study

【24h】

Predictors of Maintenance of Long-term Remission in Crohn's Disease Patients Treated With Certolizumab Pegol: Multivariate and Univariate Analyses From the PRECiSE 3 Study

机译：赛妥珠单抗治疗后克罗恩病患者长期缓解的预测指标：PRECiSE 3研究的多变量和单变量分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2014年第2期|共1页
作者
Sandborn William; Schreiber Stefan; Siegel Corey; Melmed Gil; McGovern Dermot; Pierre-Louis Bosny; Kosutic Gordana; Spearman Marshall;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Predictors of Maintenance of Long-term Remission in Crohn's Disease Patients Treated With Certolizumab Pegol: Multivariate and Univariate Analyses From the PRECiSE 3 Study [J] . Sandborn William, Schreiber Stefan, Siegel Corey, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：赛妥珠单抗治疗后克罗恩病患者长期缓解的预测指标：PRECiSE 3研究的多变量和单变量分析
2. Crohn's Disease Behavior as a Risk Factor for Loss of Maintenance of Remission in Patients Treated With Certolizumab Pegol: Results From the PRECiSE 3 Study [J] . Rubin David, Randall Charles, Coarse Jason, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：克罗恩病行为是接受Certolizumab Pegol治疗的患者失去维持缓解的危险因素：PRECiSE 3研究的结果
3. Serum Albumin as a Predictor of Long-Term Response and Remission With Certolizumab Pegol for Crohn's Disease: Results From 7-Year Data From the PRECiSE 3 Study [J] . Sandborn William, Macrae Finlay, Lawrance Ian, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：血清白蛋白可预测长期使用Certolizumab Pegol对克罗恩病的应答和缓解：来自PRECiSE 3研究的7年数据结果
4. Machine learning methods to predict presence of intestine damage in patients with Crohn's disease [C] . Binu E. Enchakalody, Brianna Henderson, Stewart C. Wang, Medical Imaging Conference . 2020

机译：机器学习方法来预测克罗恩病患者肠道损伤的存在
5. Efficacy of Pharmacological Agents on The Remission Induction and Maintenance of Crohn’s Disease [D] . Farooq, Jeffrey 2019

机译：药理剂对克罗恩病减产和维持的疗效
6. Reinduction with Certolizumab Pegol in Patients with Crohns Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study [O] . Scott D. Lee, David T. Rubin, William J. Sandborn, -1

机译：患有疾病加重的克罗恩病患者用西妥昔单抗聚乙二醇化还原：来自PRECiSE 4研究的7年数据
7. P-099 Current Smoking Status Is a Risk Factor For Loss of Remission in Crohnʼs Disease Patients Treated with Certolizumab Pegol [O] . Regueiro Miguel, Rubin David, Randall Charles, 2014

机译：P-099目前的吸烟状态是克罗恩病患者患者的缓解损失的危险因素，用于治疗的extolizumab pegol

Predictors of Maintenance of Long-term Remission in Crohn's Disease Patients Treated With Certolizumab Pegol: Multivariate and Univariate Analyses From the PRECiSE 3 Study

著录项

相似文献

相关主题

期刊订阅